{"hands_on_practices": [{"introduction": "The activation of a T cell is governed by a delicate balance between co-stimulatory signals, primarily from CD28, and co-inhibitory signals from receptors like CTLA-4. A key principle determining this balance is the competitive binding of these receptors to shared ligands on antigen-presenting cells. This exercise demonstrates quantitatively how CTLA-4's superior binding affinity for the ligand CD80 allows it to effectively dominate the interaction, providing a concrete biophysical basis for its potent regulatory function [@problem_id:2841568].", "problem": "A T cell forms an immunological synapse with an antigen-presenting cell (APC). Within the contact microdomain of area $A = 10\\,\\mu\\mathrm{m}^{2}$ and cleft thickness $t = 0.015\\,\\mu\\mathrm{m}$, the APC expresses the ligand CD80 at surface density $\\rho_{L} = 10\\,\\mathrm{molecules}/\\mu\\mathrm{m}^{2}$, while the T cell expresses the co-stimulatory receptor CD28 at surface density $\\rho_{28} = 30\\,\\mathrm{molecules}/\\mu\\mathrm{m}^{2}$ and the co-inhibitory receptor Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) at surface density $\\rho_{\\mathrm{CTLA}} = 10\\,\\mathrm{molecules}/\\mu\\mathrm{m}^{2}$. Assume $1:1$ binding stoichiometry and no multivalency.\n\nFor the receptor–ligand pairs CTLA-4:CD80 and CD28:CD80, the three-dimensional kinetic parameters are:\n- CTLA-4:CD80: $k_{\\mathrm{on,CTLA}} = 5.0 \\times 10^{5}\\,\\mathrm{M}^{-1}\\mathrm{s}^{-1}$, $k_{\\mathrm{off,CTLA}} = 0.20\\,\\mathrm{s}^{-1}$.\n- CD28:CD80: $k_{\\mathrm{on,28}} = 2.0 \\times 10^{5}\\,\\mathrm{M}^{-1}\\mathrm{s}^{-1}$, $k_{\\mathrm{off,28}} = 0.80\\,\\mathrm{s}^{-1}$.\n\nUse the following foundational definitions and assumptions:\n- The effective reaction volume of the synaptic cleft is $V = A \\times t$.\n- Avogadro’s number is $N_{A} = 6.022 \\times 10^{23}\\,\\mathrm{mol}^{-1}$.\n- For each pair $i \\in \\{\\mathrm{CTLA}, 28\\}$, the dissociation constant is $K_{d,i} = k_{\\mathrm{off},i}/k_{\\mathrm{on},i}$, and at thermodynamic equilibrium the Law of Mass Action holds for concentrations, $[C_{i}] = [R_{i,\\mathrm{free}}]\\,[L_{\\mathrm{free}}]/K_{d,i}$.\n\nTreat all species as well-mixed within $V$ and convert surface densities to absolute molecule numbers in the microdomain by multiplying by $A$. Let $f_{\\mathrm{CTLA}}$ and $f_{28}$ denote the fractions of total CD80 molecules engaged by CTLA-4 and by CD28, respectively, at equilibrium. Define a Net Co-stimulation Index (NCI) by\n$$\nI \\equiv f_{28} - f_{\\mathrm{CTLA}}.\n$$\n\nStarting only from the definitions above, compute $I$ at equilibrium. Express the final answer for $I$ as a dimensionless decimal, rounded to four significant figures.", "solution": "The problem asks for the Net Co-stimulation Index, $I$, at thermodynamic equilibrium for a competitive binding system involving two receptors (CD28, CTLA-4) and a single ligand (CD80). The index is defined as $I \\equiv f_{28} - f_{\\mathrm{CTLA}}$, where $f_{i}$ is the fraction of total ligand molecules (CD80) bound by receptor species $i$.\n\nFirst, we must validate the problem statement. The problem is scientifically grounded in immunology and biophysical chemistry, using the Law of Mass Action. It is well-posed, objective, and provides all necessary data to establish a system of equations for the equilibrium state. The parameters are within physically plausible ranges. The problem is therefore deemed valid and a solution will be derived.\n\nThe core of the problem is to determine the equilibrium concentrations of all species in the synaptic cleft, which is modeled as a well-mixed volume $V$.\n\n1.  **Calculate Total Molecule Numbers and Synaptic Volume**\n    The area of the synapse is $A = 10\\,\\mu\\mathrm{m}^{2}$ and the cleft thickness is $t = 0.015\\,\\mu\\mathrm{m}$. The total number of each molecule species in the synapse is its surface density multiplied by the area $A$.\n    -   Total CD80 ligands: $N_{L, \\mathrm{tot}} = \\rho_{L} \\times A = (10\\,\\mathrm{molecules}/\\mu\\mathrm{m}^{2}) \\times (10\\,\\mu\\mathrm{m}^{2}) = 100\\,\\mathrm{molecules}$.\n    -   Total CD28 receptors: $N_{28, \\mathrm{tot}} = \\rho_{28} \\times A = (30\\,\\mathrm{molecules}/\\mu\\mathrm{m}^{2}) \\times (10\\,\\mu\\mathrm{m}^{2}) = 300\\,\\mathrm{molecules}$.\n    -   Total CTLA-4 receptors: $N_{\\mathrm{CTLA}, \\mathrm{tot}} = \\rho_{\\mathrm{CTLA}} \\times A = (10\\,\\mathrm{molecules}/\\mu\\mathrm{m}^{2}) \\times (10\\,\\mu\\mathrm{m}^{2}) = 100\\,\\mathrm{molecules}$.\n\n    The effective reaction volume $V$ is given by $V = A \\times t$. We must convert this to liters to be consistent with molar concentrations.\n    $V = (10\\,\\mu\\mathrm{m}^{2}) \\times (0.015\\,\\mu\\mathrm{m}) = 0.15\\,\\mu\\mathrm{m}^{3}$.\n    Since $1\\,\\mu\\mathrm{m} = 10^{-4}\\,\\mathrm{cm}$, and $1\\,\\mathrm{L} = 1000\\,\\mathrm{cm}^{3}$:\n    $V = 0.15 \\times (10^{-4}\\,\\mathrm{cm})^{3} = 0.15 \\times 10^{-12}\\,\\mathrm{cm}^{3} = 0.15 \\times 10^{-15}\\,\\mathrm{L} = 1.5 \\times 10^{-16}\\,\\mathrm{L}$.\n\n2.  **Calculate Total Molar Concentrations and Dissociation Constants**\n    Using Avogadro's number, $N_{A} = 6.022 \\times 10^{23}\\,\\mathrm{mol}^{-1}$, we convert total molecule numbers to total molar concentrations, $[X_{\\mathrm{tot}}] = N_{X, \\mathrm{tot}} / (N_{A}V)$.\n    The term $N_{A}V = (6.022 \\times 10^{23}\\,\\mathrm{mol}^{-1}) \\times (1.5 \\times 10^{-16}\\,\\mathrm{L}) \\approx 9.033 \\times 10^{7}$.\n    -   $[L_{\\mathrm{tot}}] = 100 / (9.033 \\times 10^{7}) \\approx 1.107 \\times 10^{-6}\\,\\mathrm{M}$.\n    -   $[R_{28, \\mathrm{tot}}] = 300 / (9.033 \\times 10^{7}) \\approx 3.321 \\times 10^{-6}\\,\\mathrm{M}$.\n    -   $[R_{\\mathrm{CTLA}, \\mathrm{tot}}] = 100 / (9.033 \\times 10^{7}) \\approx 1.107 \\times 10^{-6}\\,\\mathrm{M}$.\n\n    The three-dimensional dissociation constants, $K_{d,i} = k_{\\mathrm{off},i} / k_{\\mathrm{on},i}$, are:\n    -   $K_{d,\\mathrm{CTLA}} = \\frac{0.20\\,\\mathrm{s}^{-1}}{5.0 \\times 10^{5}\\,\\mathrm{M}^{-1}\\mathrm{s}^{-1}} = 4.0 \\times 10^{-7}\\,\\mathrm{M}$.\n    -   $K_{d,28} = \\frac{0.80\\,\\mathrm{s}^{-1}}{2.0 \\times 10^{5}\\,\\mathrm{M}^{-1}\\mathrm{s}^{-1}} = 4.0 \\times 10^{-6}\\,\\mathrm{M}$.\n\n3.  **Set Up and Solve Equilibrium Equations**\n    At equilibrium, we have three conservation-of-mass equations and two Law of Mass Action equations. Let $[L_{\\mathrm{free}}]$, $[R_{28, \\mathrm{free}}]$, $[R_{\\mathrm{CTLA}, \\mathrm{free}}]$ be the concentrations of free species, and $[C_{28}]$, $[C_{\\mathrm{CTLA}}]$ be the concentrations of the CD28:CD80 and CTLA-4:CD80 complexes.\n\n    -   Mass Conservation:\n        $[L_{\\mathrm{tot}}] = [L_{\\mathrm{free}}] + [C_{28}] + [C_{\\mathrm{CTLA}}]$\n        $[R_{28, \\mathrm{tot}}] = [R_{28, \\mathrm{free}}] + [C_{28}]$\n        $[R_{\\mathrm{CTLA}, \\mathrm{tot}}] = [R_{\\mathrm{CTLA}, \\mathrm{free}}] + [C_{\\mathrm{CTLA}}]$\n    -   Law of Mass Action:\n        $[C_{28}] = \\frac{[R_{28, \\mathrm{free}}] [L_{\\mathrm{free}}]}{K_{d,28}}$\n        $[C_{\\mathrm{CTLA}}] = \\frac{[R_{\\mathrm{CTLA}, \\mathrm{free}}] [L_{\\mathrm{free}}]}{K_{d,\\mathrm{CTLA}}}$\n\n    By substituting the conservation relations for receptors into the mass action equations, we express the complex concentrations in terms of the free ligand concentration, $[L_{\\mathrm{free}}]$:\n    $[C_{28}] = \\frac{[R_{28, \\mathrm{tot}}] [L_{\\mathrm{free}}]}{K_{d,28} + [L_{\\mathrm{free}}]}$\n    $[C_{\\mathrm{CTLA}}] = \\frac{[R_{\\mathrm{CTLA}, \\mathrm{tot}}] [L_{\\mathrm{free}}]}{K_{d,\\mathrm{CTLA}} + [L_{\\mathrm{free}}]}$\n\n    Substituting these into the ligand conservation equation yields a single master equation for $[L_{\\mathrm{free}}]$:\n    $$[L_{\\mathrm{tot}}] = [L_{\\mathrm{free}}] + \\frac{[R_{28, \\mathrm{tot}}] [L_{\\mathrm{free}}]}{K_{d,28} + [L_{\\mathrm{free}}]} + \\frac{[R_{\\mathrm{CTLA}, \\mathrm{tot}}] [L_{\\mathrm{free}}]}{K_{d,\\mathrm{CTLA}} + [L_{\\mathrm{free}}]}$$\n\n    Let $x = [L_{\\mathrm{free}}]$. We must solve for $x$. For simplicity, let's work in units of micromolar ($\\mu\\mathrm{M}$), where $1\\,\\mu\\mathrm{M} = 10^{-6}\\,\\mathrm{M}$.\n    -   $[L_{\\mathrm{tot}}] \\approx 1.107\\,\\mu\\mathrm{M}$\n    -   $[R_{28, \\mathrm{tot}}] \\approx 3.321\\,\\mu\\mathrm{M}$\n    -   $[R_{\\mathrm{CTLA}, \\mathrm{tot}}] \\approx 1.107\\,\\mu\\mathrm{M}$\n    -   $K_{d,28} = 4.0\\,\\mu\\mathrm{M}$\n    -   $K_{d,\\mathrm{CTLA}} = 0.4\\,\\mu\\mathrm{M}$\n\n    The equation becomes:\n    $$1.107 = x + \\frac{3.321\\,x}{4.0 + x} + \\frac{1.107\\,x}{0.4 + x}$$\n    This can be rearranged into a cubic polynomial equation for $x$. Solving this equation numerically gives the concentration of free ligand:\n    $x = [L_{\\mathrm{free}}] \\approx 0.3398\\,\\mu\\mathrm{M}$.\n\n4.  **Calculate Complex Concentrations and Fractions**\n    Using the value of $[L_{\\mathrm{free}}]$, we find the equilibrium concentrations of the complexes:\n    $[C_{\\mathrm{CTLA}}] = \\frac{1.107\\,\\mu\\mathrm{M} \\times 0.3398\\,\\mu\\mathrm{M}}{0.4\\,\\mu\\mathrm{M} + 0.3398\\,\\mu\\mathrm{M}} \\approx 0.5084\\,\\mu\\mathrm{M}$.\n    $[C_{28}] = \\frac{3.321\\,\\mu\\mathrm{M} \\times 0.3398\\,\\mu\\mathrm{M}}{4.0\\,\\mu\\mathrm{M} + 0.3398\\,\\mu\\mathrm{M}} \\approx 0.2600\\,\\mu\\mathrm{M}$.\n\n    The fraction of total ligand (CD80) engaged by each receptor is the ratio of the complex concentration to the total ligand concentration:\n    $f_{\\mathrm{CTLA}} = \\frac{[C_{\\mathrm{CTLA}}]}{[L_{\\mathrm{tot}}]} = \\frac{0.5084\\,\\mu\\mathrm{M}}{1.107\\,\\mu\\mathrm{M}} \\approx 0.4593$.\n    $f_{28} = \\frac{[C_{28}]}{[L_{\\mathrm{tot}}]} = \\frac{0.2600\\,\\mu\\mathrm{M}}{1.107\\,\\mu\\mathrm{M}} \\approx 0.2349$.\n\n5.  **Compute the Net Co-stimulation Index (NCI)**\n    Finally, we compute the index $I$:\n    $I = f_{28} - f_{\\mathrm{CTLA}} \\approx 0.2349 - 0.4593 = -0.2244$.\n    The negative value indicates that at equilibrium, inhibitory signaling through CTLA-4 engagement dominates over co-stimulatory signaling through CD28 engagement, under these specified conditions. This is a direct consequence of the higher binding affinity (lower $K_d$) of CTLA-4 for CD80 compared to CD28.\n\n    Rounding the final answer to four significant figures gives $-0.2244$.", "answer": "$$ \\boxed{-0.2244} $$", "id": "2841568"}, {"introduction": "CTLA-4's function extends beyond simply outcompeting CD28 for ligand binding; it also actively removes its ligands from the surface of antigen-presenting cells through a process called trans-endocytosis. This dynamic mechanism physically depletes the source of co-stimulation, representing a profound and durable form of inhibition. This practice challenges you to model the kinetics of this process, deriving the timescale over which CTLA-4 can clear its ligand and thereby suppress the T cell response [@problem_id:2841567].", "problem": "Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4) on a T cell removes the co-stimulatory ligand CD80 from an antigen-presenting cell (APC) via trans-endocytosis during stable synaptic contact. Programmed cell death protein 1 (PD-1) does not mediate trans-endocytosis and, for the time window considered, its signaling does not alter CD80 abundance; thus, PD-1 can be ignored in the depletion dynamics. Consider a single, continuous T cell–APC contact of area $A$ in which two-dimensional reaction–internalization kinetics govern CD80 loss. Let $L(t)$ denote the synaptic surface density of unbound CD80 (molecules $\\mu\\mathrm{m}^{-2}$) on the APC, $R_f(t)$ the free CTLA-4 density (molecules $\\mu\\mathrm{m}^{-2}$) on the T cell within the contact, and $C(t)$ the density of CTLA-4:CD80 complexes (molecules $\\mu\\mathrm{m}^{-2}$). The following experimentally supported parameter values apply within the contact:\n- Two-dimensional association rate $k_{\\mathrm{on}} = 1.0 \\times 10^{-4}\\,\\mu\\mathrm{m}^{2}\\,\\mathrm{molecule}^{-1}\\,\\mathrm{s}^{-1}$.\n- Dissociation rate $k_{\\mathrm{off}} = 0.020\\,\\mathrm{s}^{-1}$.\n- Internalization rate of the bound complex $k_{\\mathrm{int}} = 0.0050\\,\\mathrm{s}^{-1}$.\n- Total CTLA-4 density in the contact $R_T = 50\\,\\mathrm{molecules}\\,\\mu\\mathrm{m}^{-2}$.\n- Initial CD80 density $L_0 = 200\\,\\mathrm{molecules}\\,\\mu\\mathrm{m}^{-2}$ at time $t=0$.\n- Contact area $A = 20\\,\\mu\\mathrm{m}^{2}$ (note: you may work with densities; the area cancels in the derived expression).\n\nAssumptions:\n- Binding, unbinding, and internalization dynamics are well described by two-dimensional mass-action kinetics on the contact interface.\n- Over the depletion timescale, the complex $C(t)$ is in quasi-steady state relative to $L(t)$ (i.e., $dC/dt \\approx 0$), and intracellular recycling or de novo synthesis of CD80 is negligible.\n- Programmed cell death protein 1 (PD-1) engagement does not alter CD80 numbers directly or indirectly over the modeled timescale.\n\nStarting from mass-action kinetics and conservation $R_f(t) + C(t) = R_T$, derive a closed-form expression for the time $t_{50}$ at which the unbound CD80 density satisfies $L(t_{50}) = L_0/2$. Then evaluate $t_{50}$ numerically with the given parameters. Express your final result in minutes and round to $4$ significant figures.", "solution": "The user has provided a problem statement that requires validation before a solution is attempted.\n\nFirst, validation of the problem statement.\n\nThe givens extracted from the problem statement are as follows:\n- Unbound CD80 density on the antigen-presenting cell (APC) is denoted by $L(t)$.\n- Free CTLA-4 density on the T cell is denoted by $R_f(t)$.\n- CTLA-4:CD80 complex density is denoted by $C(t)$.\n- The kinetic parameters are:\n  - Association rate: $k_{\\mathrm{on}} = 1.0 \\times 10^{-4}\\,\\mu\\mathrm{m}^{2}\\,\\mathrm{molecule}^{-1}\\,\\mathrm{s}^{-1}$.\n  - Dissociation rate: $k_{\\mathrm{off}} = 0.020\\,\\mathrm{s}^{-1}$.\n  - Internalization rate of the complex: $k_{\\mathrm{int}} = 0.0050\\,\\mathrm{s}^{-1}$.\n- Total CTLA-4 density in the contact area is constant: $R_T = 50\\,\\mathrm{molecules}\\,\\mu\\mathrm{m}^{-2}$.\n- The conservation law for CTLA-4 is given by $R_f(t) + C(t) = R_T$.\n- The initial condition for unbound CD80 density at time $t=0$ is $L(0) = L_0 = 200\\,\\mathrm{molecules}\\,\\mu\\mathrm{m}^{-2}$.\n- The contact area is $A = 20\\,\\mu\\mathrm{m}^{2}$.\n- The quasi-steady-state approximation (QSSA) for the complex is assumed: $dC/dt \\approx 0$.\n- The objective is to find the time $t_{50}$ at which the unbound CD80 density is half of its initial value, i.e., $L(t_{50}) = L_0/2$.\n\nThe problem is a standard exercise in biophysical modeling, grounded in the established theory of chemical kinetics. It uses mass-action principles and the quasi-steady-state assumption to simplify a system of differential equations, which is a rigorous and common approach in systems biology. The parameters are provided with consistent units, and the objective is clearly defined. The problem is scientifically grounded, well-posed, and objective. It is therefore deemed valid.\n\nWe now proceed to the solution.\nThe dynamics of the system are described by a set of coupled ordinary differential equations based on mass-action kinetics. The rate of change of the complex density, $C$, is given by its formation from free ligand $L$ and free receptor $R_f$, and its loss through dissociation and internalization:\n$$ \\frac{dC}{dt} = k_{\\mathrm{on}} L(t) R_f(t) - k_{\\mathrm{off}} C(t) - k_{\\mathrm{int}} C(t) = k_{\\mathrm{on}} L(t) R_f(t) - (k_{\\mathrm{off}} + k_{\\mathrm{int}}) C(t) $$\nThe rate of change of the unbound ligand, $L$, is determined by its consumption to form the complex and its production from the dissociation of the complex:\n$$ \\frac{dL}{dt} = -k_{\\mathrm{on}} L(t) R_f(t) + k_{\\mathrm{off}} C(t) $$\nThe problem states that the complex $C(t)$ is in a quasi-steady state, meaning its concentration adjusts rapidly to changes in $L(t)$. We apply the QSSA by setting $dC/dt \\approx 0$:\n$$ k_{\\mathrm{on}} L(t) R_f(t) - (k_{\\mathrm{off}} + k_{\\mathrm{int}}) C(t) \\approx 0 $$\nWe also use the conservation of total CTLA-4 receptor density, $R_f(t) = R_T - C(t)$, and substitute it into the QSSA equation:\n$$ k_{\\mathrm{on}} L(t) (R_T - C(t)) - (k_{\\mathrm{off}} + k_{\\mathrm{int}}) C(t) \\approx 0 $$\n$$ k_{\\mathrm{on}} L(t) R_T - k_{\\mathrm{on}} L(t) C(t) - (k_{\\mathrm{off}} + k_{\\mathrm{int}}) C(t) \\approx 0 $$\nSolving for $C(t)$ in terms of $L(t)$:\n$$ k_{\\mathrm{on}} L(t) R_T \\approx (k_{\\mathrm{on}} L(t) + k_{\\mathrm{off}} + k_{\\mathrm{int}}) C(t) $$\n$$ C(t) \\approx \\frac{k_{\\mathrm{on}} R_T L(t)}{k_{\\mathrm{on}} L(t) + k_{\\mathrm{off}} + k_{\\mathrm{int}}} $$\nThis expression gives the density of the complex as a function of the unbound ligand density under the QSSA.\nThe total amount of CD80 on the APC surface, $L_{\\mathrm{total}}(t) = L(t) + C(t)$, is depleted solely through the internalization of the complex $C(t)$ at a rate $k_{\\mathrm{int}}$. Thus, the rate of change of total ligand is $d(L+C)/dt = -k_{\\mathrm{int}} C$. Combining this with the equations for $dL/dt$ and $dC/dt$ shows consistency. The question directly asks for the time evolution of $L(t)$. We must use the equation for $dL/dt$.\nSubstituting $R_f(t) = R_T-C(t)$ into the equation for $dL/dt$:\n$$ \\frac{dL}{dt} = -k_{\\mathrm{on}} L(t) (R_T - C(t)) + k_{\\mathrm{off}} C(t) = -k_{\\mathrm{on}} L(t) R_T + (k_{\\mathrm{on}} L(t) + k_{\\mathrm{off}}) C(t) $$\nNow, we substitute the QSSA expression for $C(t)$:\n$$ \\frac{dL}{dt} = -k_{\\mathrm{on}} L(t) R_T + (k_{\\mathrm{on}} L(t) + k_{\\mathrm{off}}) \\left( \\frac{k_{\\mathrm{on}} R_T L(t)}{k_{\\mathrm{on}} L(t) + k_{\\mathrm{off}} + k_{\\mathrm{int}}} \\right) $$\nFactoring out $-k_{\\mathrm{on}} L(t) R_T$:\n$$ \\frac{dL}{dt} = -k_{\\mathrm{on}} L(t) R_T \\left( 1 - \\frac{k_{\\mathrm{on}} L(t) + k_{\\mathrm{off}}}{k_{\\mathrm{on}} L(t) + k_{\\mathrm{off}} + k_{\\mathrm{int}}} \\right) $$\nPutting the terms in the parenthesis over a common denominator:\n$$ \\frac{dL}{dt} = -k_{\\mathrm{on}} L(t) R_T \\left( \\frac{(k_{\\mathrm{on}} L(t) + k_{\\mathrm{off}} + k_{\\mathrm{int}}) - (k_{\\mathrm{on}} L(t) + k_{\\mathrm{off}})}{k_{\\mathrm{on}} L(t) + k_{\\mathrm{off}} + k_{\\mathrm{int}}} \\right) $$\nThis simplifies to:\n$$ \\frac{dL}{dt} = -k_{\\mathrm{on}} L(t) R_T \\left( \\frac{k_{\\mathrm{int}}}{k_{\\mathrm{on}} L(t) + k_{\\mathrm{off}} + k_{\\mathrm{int}}} \\right) = - \\frac{k_{\\mathrm{on}} k_{\\mathrm{int}} R_T L(t)}{k_{\\mathrm{on}} L(t) + k_{\\mathrm{off}} + k_{\\mathrm{int}}} $$\nThis is a separable first-order ordinary differential equation for $L(t)$. We separate the variables to solve for the time $t_{50}$:\n$$ \\frac{k_{\\mathrm{on}} L(t) + k_{\\mathrm{off}} + k_{\\mathrm{int}}}{L(t)} dL = - k_{\\mathrm{on}} k_{\\mathrm{int}} R_T dt $$\n$$ \\left( k_{\\mathrm{on}} + \\frac{k_{\\mathrm{off}} + k_{\\mathrm{int}}}{L} \\right) dL = - k_{\\mathrm{on}} k_{\\mathrm{int}} R_T dt $$\nWe integrate both sides. The time runs from $t=0$ to $t=t_{50}$, and the ligand density $L$ runs from $L(0)=L_0$ to $L(t_{50})=L_0/2$.\n$$ \\int_{L_0}^{L_0/2} \\left( k_{\\mathrm{on}} + \\frac{k_{\\mathrm{off}} + k_{\\mathrm{int}}}{L} \\right) dL = \\int_{0}^{t_{50}} -k_{\\mathrm{on}} k_{\\mathrm{int}} R_T dt $$\n$$ \\left[ k_{\\mathrm{on}}L + (k_{\\mathrm{off}} + k_{\\mathrm{int}}) \\ln(L) \\right]_{L_0}^{L_0/2} = \\left[ -k_{\\mathrm{on}} k_{\\mathrm{int}} R_T t \\right]_{0}^{t_{50}} $$\n$$ k_{\\mathrm{on}}\\left(\\frac{L_0}{2} - L_0\\right) + (k_{\\mathrm{off}} + k_{\\mathrm{int}})\\left(\\ln\\left(\\frac{L_0}{2}\\right) - \\ln(L_0)\\right) = -k_{\\mathrm{on}} k_{\\mathrm{int}} R_T t_{50} $$\n$$ -k_{\\mathrm{on}}\\frac{L_0}{2} + (k_{\\mathrm{off}} + k_{\\mathrm{int}})\\ln\\left(\\frac{1}{2}\\right) = -k_{\\mathrm{on}} k_{\\mathrm{int}} R_T t_{50} $$\n$$ -k_{\\mathrm{on}}\\frac{L_0}{2} - (k_{\\mathrm{off}} + k_{\\mathrm{int}})\\ln(2) = -k_{\\mathrm{on}} k_{\\mathrm{int}} R_T t_{50} $$\nMultiplying by $-1$ and solving for $t_{50}$:\n$$ t_{50} = \\frac{\\frac{1}{2} k_{\\mathrm{on}} L_0 + (k_{\\mathrm{off}} + k_{\\mathrm{int}})\\ln(2)}{k_{\\mathrm{on}} k_{\\mathrm{int}} R_T} $$\nThis is the closed-form expression for $t_{50}$. Now we substitute the given numerical values:\n- $k_{\\mathrm{on}} = 1.0 \\times 10^{-4}\\,\\mu\\mathrm{m}^{2}\\,\\mathrm{molecule}^{-1}\\,\\mathrm{s}^{-1}$\n- $k_{\\mathrm{off}} = 0.020\\,\\mathrm{s}^{-1}$\n- $k_{\\mathrm{int}} = 0.0050\\,\\mathrm{s}^{-1}$\n- $R_T = 50\\,\\mathrm{molecules}\\,\\mu\\mathrm{m}^{-2}$\n- $L_0 = 200\\,\\mathrm{molecules}\\,\\mu\\mathrm{m}^{-2}$\n- $\\ln(2) \\approx 0.693147$\n\nNumerator calculation:\n$ \\frac{1}{2} k_{\\mathrm{on}} L_0 = \\frac{1}{2} (1.0 \\times 10^{-4}) (200) = 0.01\\ \\mathrm{s}^{-1} $\n$ (k_{\\mathrm{off}} + k_{\\mathrm{int}})\\ln(2) = (0.020 + 0.0050) \\ln(2) = 0.025 \\ln(2) \\approx 0.017329\\ \\mathrm{s}^{-1} $\nNumerator $\\approx 0.01 + 0.017329 = 0.027329\\ \\mathrm{s}^{-1}$.\n\nDenominator calculation:\n$ k_{\\mathrm{on}} k_{\\mathrm{int}} R_T = (1.0 \\times 10^{-4}) (0.0050) (50) = 2.5 \\times 10^{-5}\\ \\mathrm{s}^{-2} $\n\nNow, we calculate $t_{50}$:\n$$ t_{50} \\approx \\frac{0.027329\\ \\mathrm{s}^{-1}}{2.5 \\times 10^{-5}\\ \\mathrm{s}^{-2}} \\approx 1093.16\\ \\mathrm{s} $$\nThe problem asks for the result in minutes, rounded to $4$ significant figures.\n$$ t_{50} \\approx \\frac{1093.16}{60}\\ \\mathrm{min} \\approx 18.2193\\ \\mathrm{min} $$\nRounding to $4$ significant figures gives $18.22$ minutes.\nNote that the contact area $A$ was not required, as the problem was formulated entirely in terms of surface densities.", "answer": "$$\\boxed{18.22}$$", "id": "2841567"}, {"introduction": "While CTLA-4 primarily regulates the initial priming of T cells, PD-1 is crucial for tuning the activity of effector T cells in peripheral tissues, often in the context of chronic infection or cancer. One of PD-1's key downstream effects is the profound reprogramming of T cell metabolism, promoting a shift from aerobic glycolysis to fatty acid oxidation. This practice provides a quantitative framework to analyze the consequences of this metabolic switch, allowing you to calculate the net change in a T cell's energy production rate and appreciate the bioenergetic basis of T cell exhaustion [@problem_id:2841519].", "problem": "A subset of activated T lymphocytes relies on aerobic glycolysis for rapid Adenosine Triphosphate (ATP) supply, while fatty acid oxidation (FAO) contributes a smaller but efficient ATP yield. Programmed cell death protein 1 (PD-1) signaling is known to suppress glycolytic flux and promote FAO flux, whereas Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4) predominantly dampens co-stimulation and early metabolic upshift. Consider a two-pathway model in which total ATP production rate is the sum of contributions from glycolysis and FAO, each given by the product of pathway flux and its stoichiometric ATP yield. Assume:\n- Glycolysis yields $y_{g} = 2$ mol ATP per mol glucose (to lactate).\n- FAO of palmitate yields $y_{f} = 106$ mol ATP per mol palmitate (complete oxidation).\n- Baseline glycolytic substrate flux is $J_{g}^{0} = 0.50$ nmol glucose per minute per $10^{6}$ T cells.\n- Baseline FAO substrate flux is $J_{f}^{0} = 0.0030$ nmol palmitate per minute per $10^{6}$ T cells.\n- Upon PD-1 engagement, glycolytic flux is reduced by a fraction $r_{g} = 0.60$ and FAO flux is increased by a fraction $r_{f} = 0.40$. Yields $y_{g}$ and $y_{f}$ do not change, and pathway contributions to ATP production are additive.\n\nUsing only these definitions and the additivity of pathway ATP contributions, derive from first principles the fold-change $\\mathcal{F}$ in total ATP production rate after PD-1 engagement relative to baseline, where\n$$\n\\mathcal{F} \\equiv \\frac{J_{\\mathrm{ATP}}^{\\mathrm{PD}\\text{-}1}}{J_{\\mathrm{ATP}}^{0}}.\n$$\nCompute the numerical value of $\\mathcal{F}$ and round your answer to four significant figures. Express $\\mathcal{F}$ as a unitless decimal.", "solution": "The problem statement is first subjected to a rigorous validation process.\n\nStep 1: Extract Givens.\nThe explicit data provided are as follows:\n- Stoichiometric ATP yield from glycolysis: $y_{g} = 2$ mol ATP per mol glucose.\n- Stoichiometric ATP yield from fatty acid oxidation (FAO) of palmitate: $y_{f} = 106$ mol ATP per mol palmitate.\n- Baseline glycolytic substrate flux: $J_{g}^{0} = 0.50$ nmol glucose per minute per $10^{6}$ T cells.\n- Baseline FAO substrate flux: $J_{f}^{0} = 0.0030$ nmol palmitate per minute per $10^{6}$ T cells.\n- Fractional reduction in glycolytic flux upon PD-1 engagement: $r_{g} = 0.60$.\n- Fractional increase in FAO flux upon PD-1 engagement: $r_{f} = 0.40$.\n- The total ATP production rate is defined as the sum of contributions from glycolysis and FAO.\n- The contribution of a pathway is the product of its substrate flux and its ATP yield.\n- The definition of the fold-change is $\\mathcal{F} \\equiv \\frac{J_{\\mathrm{ATP}}^{\\mathrm{PD}\\text{-}1}}{J_{\\mathrm{ATP}}^{0}}$.\n\nStep 2: Validate Using Extracted Givens.\nThe problem is evaluated against the required criteria.\n- **Scientifically Grounded**: The problem presents a simplified but biologically sound model of T-cell immunometabolism. The stated effects of PD-1 signaling on glycolysis and FAO are consistent with established research. The ATP yields for glycolysis to lactate ($2$ ATP/glucose) and complete oxidation of palmitate (approximately $106$ ATP/palmitate) are standard biochemical values. The problem is a valid, quantitative representation of a known biological phenomenon.\n- **Well-Posed**: All necessary parameters and definitions are provided to compute a unique numerical value for the requested quantity, $\\mathcal{F}$. The problem is self-contained and mathematically solvable.\n- **Objective**: The problem is stated using precise, quantitative language, free of subjective or ambiguous terminology.\n\nThe problem contains no scientific or factual unsoundness, is formalizable and relevant, is complete and consistent, presents a realistic (though simplified) scenario, and is well-posed. It is not trivial, as it requires correct application of definitions to construct the solution. Therefore, the problem is deemed valid. We proceed to the solution.\n\nThe total ATP production rate, $J_{\\mathrm{ATP}}$, is the sum of the rates from glycolysis, $J_{\\mathrm{ATP},g}$, and fatty acid oxidation, $J_{\\mathrm{ATP},f}$.\n$$\nJ_{\\mathrm{ATP}} = J_{\\mathrm{ATP},g} + J_{\\mathrm{ATP},f}\n$$\nThe contribution of each pathway is the product of its substrate flux and stoichiometric ATP yield.\nThus, the baseline total ATP production rate, $J_{\\mathrm{ATP}}^{0}$, is given by:\n$$\nJ_{\\mathrm{ATP}}^{0} = J_{g}^{0} y_{g} + J_{f}^{0} y_{f}\n$$\nUpon engagement of PD-1, the glycolytic flux, $J_{g}^{0}$, is reduced by a fraction $r_{g}$. The new glycolytic flux, $J_{g}^{\\mathrm{PD}\\text{-}1}$, is:\n$$\nJ_{g}^{\\mathrm{PD}\\text{-}1} = J_{g}^{0} (1 - r_{g})\n$$\nSimultaneously, the FAO flux, $J_{f}^{0}$, is increased by a fraction $r_{f}$. The new FAO flux, $J_{f}^{\\mathrm{PD}\\text{-}1}$, is:\n$$\nJ_{f}^{\\mathrm{PD}\\text{-}1} = J_{f}^{0} (1 + r_{f})\n$$\nThe yields $y_{g}$ and $y_{f}$ are stated to be constant. The total ATP production rate after PD-1 engagement, $J_{\\mathrm{ATP}}^{\\mathrm{PD}\\text{-}1}$, is therefore:\n$$\nJ_{\\mathrm{ATP}}^{\\mathrm{PD}\\text{-}1} = J_{g}^{\\mathrm{PD}\\text{-}1} y_{g} + J_{f}^{\\mathrm{PD}\\text{-}1} y_{f} = J_{g}^{0} (1 - r_{g}) y_{g} + J_{f}^{0} (1 + r_{f}) y_{f}\n$$\nThe problem demands the calculation of the fold-change $\\mathcal{F}$, defined as the ratio of the ATP production rate with PD-1 engagement to the baseline rate.\n$$\n\\mathcal{F} = \\frac{J_{\\mathrm{ATP}}^{\\mathrm{PD}\\text{-}1}}{J_{\\mathrm{ATP}}^{0}} = \\frac{J_{g}^{0} (1 - r_{g}) y_{g} + J_{f}^{0} (1 + r_{f}) y_{f}}{J_{g}^{0} y_{g} + J_{f}^{0} y_{f}}\n$$\nWe now substitute the provided numerical values into this expression.\nThe givens are: $y_{g} = 2$, $y_{f} = 106$, $J_{g}^{0} = 0.50$, $J_{f}^{0} = 0.0030$, $r_{g} = 0.60$, and $r_{f} = 0.40$.\n\nFirst, we calculate the denominator, which is the baseline ATP production rate, $J_{\\mathrm{ATP}}^{0}$.\n$$\nJ_{\\mathrm{ATP}}^{0} = (0.50) \\cdot (2) + (0.0030) \\cdot (106) = 1.00 + 0.318 = 1.318\n$$\nThe units are nmol ATP per minute per $10^{6}$ T cells, but these cancel in the final ratio.\n\nNext, we calculate the numerator, which is the ATP production rate after PD-1 engagement, $J_{\\mathrm{ATP}}^{\\mathrm{PD}\\text{-}1}$.\n$$\nJ_{\\mathrm{ATP}}^{\\mathrm{PD}\\text{-}1} = J_{g}^{0} (1 - r_{g}) y_{g} + J_{f}^{0} (1 + r_{f}) y_{f}\n$$\n$$\nJ_{\\mathrm{ATP}}^{\\mathrm{PD}\\text{-}1} = (0.50) \\cdot (1 - 0.60) \\cdot (2) + (0.0030) \\cdot (1 + 0.40) \\cdot (106)\n$$\n$$\nJ_{\\mathrm{ATP}}^{\\mathrm{PD}\\text{-}1} = (0.50) \\cdot (0.40) \\cdot (2) + (0.0030) \\cdot (1.40) \\cdot (106)\n$$\n$$\nJ_{\\mathrm{ATP}}^{\\mathrm{PD}\\text{-}1} = (0.20) \\cdot (2) + (0.0042) \\cdot (106)\n$$\n$$\nJ_{\\mathrm{ATP}}^{\\mathrm{PD}\\text{-}1} = 0.400 + 0.4452 = 0.8452\n$$\nFinally, we compute the fold-change $\\mathcal{F}$.\n$$\n\\mathcal{F} = \\frac{0.8452}{1.318} \\approx 0.641274658...\n$$\nThe problem requires the answer to be rounded to four significant figures.\n$$\n\\mathcal{F} \\approx 0.6413\n$$\nThis result signifies that PD-1 engagement, under the specified conditions, leads to an overall decrease in the rate of ATP production to approximately $64.13\\%$ of its baseline level, despite the upregulation of the more efficient FAO pathway. This is due to the substantial reduction in the high-flux, albeit less efficient, glycolytic pathway.", "answer": "$$\n\\boxed{0.6413}\n$$", "id": "2841519"}]}